INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2019

Soy milk consumption alongside a calorie-deficit diet improved insulin, insulin resistance, and blood pressure in patients with NAFLD.

Sixty-six patients with NAFLD were randomly assigned to a 500-calorie deficit diet either with or without 240 ml/day of soy milk for 8 weeks. Compared to the control group, the soy milk group showed significantly greater reductions in serum insulin (-3.44 ± 5.02 vs. -1.09 ± 3.77 μIU/ml, P = 0.04), HOMA-IR (-0.45 ± 0.64 vs -0.14 ± 0.47, P = 0.03), systolic BP (-3.81 ± 4.15 vs -1.48 ± 2.93 mmHg, P = 0.01), and diastolic BP (-2.39 ± 2.80 vs. -0.94 ± 2.76 mmHg, P = 0.04), plus a significant increase in QUICKI (0.02 ± 0.032 vs. 0.008 ± 0.018, P = 0.04). Changes in fasting blood sugar, HOMA-β%, fibrinogen, and malondialdehyde did not differ significantly between groups.

Study type
Randomized, parallel, controlled trial
Who was studied
66 patients diagnosed with non-alcoholic fatty liver disease (NAFLD)
What was measured
Fasting blood sugar, insulin, HOMA-IR, HOMA-β%, QUICKI, MDA, fibrinogen, and blood pressure

THE PAPER

Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial.

Maleki Z, Jazayeri S, Eslami O, Shidfar F, Hosseini AF, Agah S, Norouzi H. Complement Ther Med, 2019.

PubMed 31126574 ↗DOI 10.1016/j.ctim.2019.02.020 ↗

Diabetes & blood sugarBlood pressureOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.